OctreoScan: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 53: | Line 53: | ||
==References== | ==References== | ||
*Ziessman, Harvey A, O'Malley, Janis P, and Thrall, James M. | *Ziessman, Harvey A, O'Malley, Janis P, and Thrall, James M. Nuclear Medicine: The Requisites. 3rd ed. Philadelphia, Pennsylvania: Mosby, 2006. ISBN 0323029469 | ||
[[Category:Nucs]] | [[Category:Nucs]] | ||
[[Category:Nucs protocol]] | [[Category:Nucs protocol]] |
Revision as of 16:53, 26 February 2009
Indications for imaging
- Tumor evaluation
Patient preparation
- Bowel preparation with laxative and enema
- Discontinue octeotide therapy for 1 week prior the exam
Radiopharmaceutical
- In-111 OctreoScan
Dose and route of administration
- 6 mCi IV
- 4 hours (abdomen, pelvis)
- 24 hours (whole body)
Equipment
- Camera: Large field of view SPECT gamma camera
- Collimator: Medium-energy
- Window: 20% window around 173 and 245 KeV
Procedure
- 4 hours: Planar images of the abdomen and pelvis
- 24 hours: Planar images of the whole body. SPECT of regions of clinical concern.
Images
Normal OctreoScan
References
- Ziessman, Harvey A, O'Malley, Janis P, and Thrall, James M. Nuclear Medicine: The Requisites. 3rd ed. Philadelphia, Pennsylvania: Mosby, 2006. ISBN 0323029469